Upgrades:
Novartis (NYSE:NVS) was upgraded by stock analysts at Cowen
from a “market perform” rating to an “outperform” rating in a note issued to
investors on Monday, The Fly reports. NVS has been the topic of a number of
other research reports. Goldman Sachs Group raised shares of Novartis from a
“neutral” rating to a “conviction-buy” rating in a report on Friday, November
16th. Bank of America raised Novartis from an “underperform” rating to a “buy”
rating and set a $74.71 price target on the stock in a report on Monday,
September 10th. Zacks Investment Research cut Novartis from a “hold” rating to
a “sell” rating in a report on Wednesday, August 29th. JPMorgan Chase & Co.
reaffirmed a “neutral” rating on shares of Novartis in a report on Thursday,
October 11th. Finally, Citigroup raised Novartis from a “neutral” rating to a
“buy” rating in a report on Tuesday, September 11th. Eleven research analysts
have rated the stock with a hold rating, six have given a buy rating and one
has given a strong buy rating to the company. The company has an average rating
of “Hold” and an average target price of $84.86. Read more …
HSBC upgraded shares of Schlumberger (NYSE:SLB) from a hold
rating to a buy rating in a research note released on Monday, Marketbeat
Ratings reports. Several other research analysts also recently commented on
SLB. Zacks Investment Research downgraded shares of Schlumberger from a hold
rating to a strong sell rating in a research report on Tuesday, October 23rd.
ValuEngine upgraded shares of Schlumberger from a sell rating to a hold rating
in a research report on Thursday, October 4th. Macquarie set a $71.00 price
objective on shares of Schlumberger and gave the company a hold rating in a
research report on Tuesday, October 2nd. Wolfe Research began coverage on
shares of Schlumberger in a research report on Wednesday, October 10th. They
set a market perform rating for the company. Finally, Stephens began coverage
on shares of Schlumberger in a research report on Friday, October 12th. They
set a weight rating for the company. Two equities research analysts have rated
the stock with a sell rating, six have assigned a hold rating and seventeen
have given a buy rating to the stock. The stock presently has a consensus
rating of Buy and an average price target of $76.94. Read more …
AT&T (NYSE:T) was upgraded by research analysts at
Moffett Nathanson from a “sell” rating to a “neutral” rating in a research note
issued to investors on Monday, MarketBeat Ratings reports. The firm presently
has a $28.00 target price on the technology company’s stock. Moffett
Nathanson’s price objective would indicate a potential downside of 8.02% from
the stock’s previous close. A number of other research firms have also recently
commented on T. Bank of America set a $37.00 target price on shares of AT&T
and gave the stock a “buy” rating in a research report on Tuesday, October
23rd. ValuEngine raised shares of AT&T from a “strong sell” rating to a
“sell” rating in a report on Wednesday, September 12th. Macquarie reaffirmed a
“buy” rating and issued a $35.00 price target on shares of AT&T in a report
on Wednesday, September 12th. Wells Fargo & Co cut shares of AT&T from
an “outperform” rating to a “market perform” rating and set a $40.00 price
target on the stock. in a report on Wednesday, August 22nd. Finally, Robert W.
Baird cut their price target on shares of AT&T from $38.00 to $35.00 and
set an “outperform” rating on the stock in a report on Thursday, October 25th. Two
investment analysts have rated the stock with a sell rating, eleven have given
a hold rating, ten have issued a buy rating and one has issued a strong buy
rating to the company. The company presently has an average rating of “Hold”
and an average price target of $36.35. Read more …
Union Pacific (NYSE:UNP) was upgraded by equities
researchers at Deutsche Bank from a “hold” rating to a “buy” rating in a report
issued on Tuesday, The Fly reports. The firm currently has a $175.00 price
objective on the railroad operator’s stock. Deutsche Bank’s price objective
would suggest a potential upside of 15.15% from the stock’s current price. Other
equities research analysts also recently issued reports about the company.
Zacks Investment Research raised Union Pacific from a “hold” rating to a “buy”
rating and set a $176.00 price target on the stock in a research report on
Wednesday, September 19th. UBS Group increased their price target on Union
Pacific from $161.00 to $185.00 and gave the stock a “buy” rating in a research
report on Thursday, September 20th. Bank of America downgraded Union Pacific
from a “buy” rating to a “neutral” rating and set a $164.00 price target on the
stock. in a research report on Thursday, October 18th. Loop Capital raised
Union Pacific from a “hold” rating to a “buy” rating in a research report on
Tuesday, September 18th. Finally, Barclays reaffirmed a “buy” rating and set a
$180.00 price target on shares of Union Pacific in a research report on
Wednesday, September 26th. One analyst has rated the stock with a sell rating,
seven have assigned a hold rating and thirteen have assigned a buy rating to
the company’s stock. The company currently has a consensus rating of “Buy” and
a consensus price target of $165.24. Read more …
UBS Group upgraded shares of United Technologies (NYSE:UTX)
from a sell rating to a hold rating in a report issued on Wednesday, The Fly
reports. UTX has been the topic of several other research reports. Robert W.
Baird upped their price target on United Technologies from $156.00 to $167.00
and gave the company a neutral rating in a research note on Thursday, September
20th. Zacks Investment Research lowered United Technologies from a buy rating
to a hold rating in a research note on Friday, October 26th. Jefferies
Financial Group set a $148.00 price target on United Technologies and gave the
company a buy rating in a research note on Tuesday. ValuEngine raised United
Technologies from a hold rating to a buy rating in a research note on Friday,
November 23rd. Finally, Wolfe Research set a $147.00 price target on United
Technologies and gave the company a buy rating in a research note on Monday.
Four investment analysts have rated the stock with a hold rating and thirteen
have assigned a buy rating to the company. The company currently has a
consensus rating of Buy and an average price target of $151.58. Read more …
Omega Healthcare Investors (NYSE:OHI) was upgraded by
analysts at Stifel Nicolaus from a “hold” rating to a “buy” rating in a
research report issued on Wednesday, The Fly reports. A number of other
equities research analysts also recently issued reports on OHI. Cantor
Fitzgerald reiterated a “buy” rating and issued a $34.00 price objective on
shares of Omega Healthcare Investors in a research report on Monday, August
6th. ValuEngine upgraded Omega Healthcare Investors from a “sell” rating to a
“hold” rating in a research report on Monday, August 13th. Zacks Investment
Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold”
rating in a research report on Thursday, August 16th. MED started coverage on
Omega Healthcare Investors in a research report on Tuesday, October 2nd. They issued
a “neutral” rating and a $31.00 price objective on the stock. They noted that
the move was a valuation call. Finally, Mitsubishi UFJ Financial Group
reiterated a “neutral” rating on shares of Omega Healthcare Investors in a
research report on Tuesday, October 2nd. Seven equities research analysts have
rated the stock with a hold rating and four have issued a buy rating to the
stock. The company has an average rating of “Hold” and a consensus price target
of $32.50. Read more …
Mcdonald’s (NYSE:MCD) was upgraded by analysts at Morgan
Stanley from an “equal weight” rating to an “overweight” rating in a note
issued to investors on Thursday, The Fly reports. Several other analysts have
also recently issued reports on the stock. Piper Jaffray Companies upped their
price target on shares of Mcdonald’s to $194.00 and gave the company an
“overweight” rating in a report on Wednesday. Zacks Investment Research cut
shares of Mcdonald’s from a “buy” rating to a “hold” rating in a report on
Tuesday. Wells Fargo & Co upped their price target on shares of Mcdonald’s
from $197.00 to $202.00 and gave the company an “outperform” rating in a report
on Wednesday, November 21st. Royal Bank of Canada set a $190.00 price target on
shares of Mcdonald’s and gave the company a “buy” rating in a report on
Tuesday, November 20th. Finally, Jefferies Financial Group set a $200.00 price
target on shares of Mcdonald’s and gave the company a “buy” rating in a report
on Tuesday, November 20th. Seven equities research analysts have rated the
stock with a hold rating and twenty-five have issued a buy rating to the
company. Mcdonald’s currently has a consensus rating of “Buy” and a consensus
target price of $190.31. Read more …
Credit Suisse Group upgraded shares of J M Smucker
(NYSE:SJM) to a hold rating in a report released on Thursday. They currently
have $94.00 price target on the stock. Several other equities research analysts
have also recently weighed in on SJM. Zacks Investment Research raised J M
Smucker from a sell rating to a hold rating in a research note on Wednesday,
November 21st. ValuEngine cut J M Smucker from a hold rating to a sell rating
in a research note on Wednesday. Morgan Stanley cut their target price on J M
Smucker from $100.00 to $98.00 and set an underweight rating on the stock in a
research note on Thursday. Jefferies Financial Group set a $125.00 target price
on J M Smucker and gave the company a buy rating in a research note on
Wednesday. Finally, Bank of America reaffirmed a neutral rating and set a
$106.00 target price on shares of J M Smucker in a research note on Wednesday, October
3rd. Four analysts have rated the stock with a sell rating, seven have issued a
hold rating and four have assigned a buy rating to the company’s stock. The
stock has an average rating of Hold and a consensus target price of $119.17. Read more …
Argus upgraded shares of TJX Companies (NYSE:TJX) from a
hold rating to a buy rating in a research note released on Thursday morning,
MarketBeat reports. Argus currently has $55.00 target price on the apparel and
home fashions retailer’s stock. Several other equities research analysts have
also recently weighed in on the stock. Goldman Sachs Group started coverage on
shares of TJX Companies in a research report on Monday, September 3rd. They set
a buy rating and a $63.00 price objective for the company. Citigroup increased
their price objective on shares of TJX Companies from $55.50 to $62.50 and gave
the stock a buy rating in a research report on Tuesday, October 16th. Deutsche
Bank increased their price objective on shares of TJX Companies from $50.00 to
$52.50 and gave the stock a buy rating in a research report on Monday, August
20th. DA Davidson started coverage on shares of TJX Companies in a research report
on Tuesday, September 25th. They set a buy rating and a $65.00 price objective
for the company. Finally, Cowen set a $62.50 price objective on shares of TJX
Companies and gave the stock a buy rating in a research report on Tuesday,
September 25th. Two analysts have rated the stock with a sell rating, ten have
issued a hold rating and seventeen have assigned a buy rating to the stock. The
company has an average rating of Buy and a consensus price target of $53.26. Read more …
Abbott Laboratories (NYSE:ABT) was upgraded by investment
analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a
research note issued on Friday, The Fly reports. The firm presently has a
$81.00 price target on the healthcare product maker’s stock. Goldman Sachs
Group’s price objective would indicate a potential upside of 10.57% from the
stock’s previous close. A number of other brokerages have also recently weighed
in on ABT. Cowen upped their price target on shares of Abbott Laboratories from
$72.00 to $86.00 and gave the stock an “average” rating in a research report on
Friday, October 5th. Jefferies Financial Group reaffirmed a “buy” rating and
set a $80.00 price target on shares of Abbott Laboratories in a research report
on Thursday, October 18th. Zacks Investment Research raised shares of Abbott
Laboratories from a “hold” rating to a “buy” rating and set a $77.00 price target
for the company in a research report on Tuesday, September 18th. UBS Group
assumed coverage on shares of Abbott Laboratories in a research report on
Tuesday. They set a “buy” rating and a $83.00 price target for the company.
Finally, BTIG Research reaffirmed a “hold” rating on shares of Abbott
Laboratories in a research report on Thursday, October 18th. One analyst has
rated the stock with a sell rating, four have given a hold rating and seventeen
have assigned a buy rating to the company. The company currently has an average
rating of “Buy” and a consensus price target of $75.90. Read more …
Downgrades:
Wolfe Research downgraded shares of Kinder Morgan (NYSE:KMI)
from a market perform rating to an underperform rating in a research report
released on Monday, The Fly reports. Several other research analysts have also
commented on KMI. Zacks Investment Research lowered Kinder Morgan from a buy
rating to a hold rating in a research report on Tuesday, November 13th.
Barclays set a $21.00 price objective on Kinder Morgan and gave the company a
buy rating in a research report on Friday, October 12th. ValuEngine raised
Kinder Morgan from a strong sell rating to a sell rating in a research report
on Wednesday, August 15th. Stifel Nicolaus raised their price objective on
Kinder Morgan from $21.00 to $23.00 and gave the company a buy rating in a
research report on Wednesday, August 1st. Finally, Goldman Sachs Group began
coverage on Kinder Morgan in a research report on Monday, October 8th. They
issued a conviction-buy rating and a $24.00 price objective on the stock. Two
analysts have rated the stock with a sell rating, three have issued a hold rating,
fifteen have given a buy rating and one has issued a strong buy rating to the
stock. The company currently has an average rating of Buy and an average target
price of $20.73. Read more …
Exxon Mobil (NYSE:XOM) was downgraded by equities
researchers at Raymond James from a “market perform” rating to an
“underperform” rating in a research note issued to investors on Tuesday,
November 20th, Marketbeat.com reports. XOM has been the topic of a number of
other research reports. Societe Generale set a $92.00 price objective on Exxon
Mobil and gave the stock a “buy” rating in a research note on Wednesday, August
22nd. HSBC reiterated a “buy” rating and set a $96.00 price objective on shares
of Exxon Mobil in a research note on Wednesday, September 12th. Credit Suisse
Group set a $80.00 price objective on Exxon Mobil and gave the stock a
“neutral” rating in a research note on Thursday, September 6th. Zacks
Investment Research raised Exxon Mobil from a “hold” rating to a “buy” rating
and set a $96.00 target price on the stock in a report on Monday, October 1st.
Finally, Piper Jaffray Companies reissued a “neutral” rating on shares of Exxon
Mobil in a report on Tuesday, October 23rd. Five analysts have rated the stock
with a sell rating, thirteen have issued a hold rating, seven have assigned a
buy rating and one has given a strong buy rating to the stock. The stock
presently has an average rating of “Hold” and an average target price of
$87.00. Read more …
Hormel Foods (NYSE:HRL) was downgraded by stock analysts at
Jefferies Financial Group from a “buy” rating to a “hold” rating in a report
released on Tuesday, The Fly reports. HRL has been the topic of a number of
other reports. Credit Suisse Group set a $39.00 target price on Hormel Foods
and gave the stock a “hold” rating in a research report on Wednesday, November
21st. BMO Capital Markets downgraded Hormel Foods from an “outperform” rating
to a “market perform” rating and boosted their target price for the stock from
$38.00 to $44.00 in a research report on Monday, September 17th. They noted
that the move was a valuation call. Zacks Investment Research upgraded Hormel
Foods from a “sell” rating to a “hold” rating in a research report on Tuesday,
August 21st. Buckingham Research boosted their target price on Hormel Foods
from $32.00 to $34.00 and gave the stock a “neutral” rating in a research
report on Thursday, August 16th. Finally, ValuEngine upgraded Hormel Foods from
a “hold” rating to a “buy” rating in a research report on Thursday, September
6th. Three research analysts have rated the stock with a sell rating, seven
have assigned a hold rating and two have assigned a buy rating to the company.
Hormel Foods has a consensus rating of “Hold” and an average price target of
$40.56. Read more …
JPMorgan Chase & Co. lowered shares of Eaton Vance
(NYSE:EV) from a neutral rating to an underweight rating in a report issued on
Wednesday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has
$38.00 target price on the asset manager’s stock. A number of other analysts
have also issued reports on the stock. Zacks Investment Research lowered shares
of Eaton Vance from a hold rating to a sell rating in a research note on
Thursday, August 9th. Citigroup dropped their price objective on shares of
Eaton Vance from $62.00 to $60.50 and set a buy rating on the stock in a
research note on Thursday, August 30th. Deutsche Bank dropped their price
objective on shares of Eaton Vance from $64.00 to $63.00 and set a buy rating
on the stock in a research note on Thursday, September 27th. ValuEngine lowered
shares of Eaton Vance from a hold rating to a sell rating in a research note on
Wednesday, October 17th. Finally, Jefferies Financial Group reiterated a hold
rating and set a $45.00 price objective on shares of Eaton Vance in a research
note on Monday, November 19th. Three analysts have rated the stock with a sell
rating, four have assigned a hold rating and two have given a buy rating to the
stock. The company currently has a consensus rating of Hold and a consensus
price target of $52.63. Read more …
Buckingham Research cut shares of American Express
(NYSE:AXP) from a buy rating to a neutral rating in a report published on
Thursday morning, MarketBeat reports. Buckingham Research currently has $112.00
price objective on the payment services company’s stock. The analysts noted
that the move was a valuation call. A number of other equities research
analysts also recently weighed in on the company. Oppenheimer set a $114.00
target price on American Express and gave the stock a buy rating in a report on
Monday, November 5th. Stephens set a $131.00 target price on American Express
and gave the stock a buy rating in a report on Saturday, October 20th. BMO
Capital Markets lifted their target price on American Express from $106.00 to
$110.00 and gave the stock a market perform rating in a report on Friday,
October 19th. Bank of America set a $125.00 target price on American Express
and gave the stock a buy rating in a report on Friday, October 19th. Finally,
Morgan Stanley lifted their target price on American Express from $109.00 to
$115.00 and gave the stock an equal weight rating in a report on Friday,
October 19th. One analyst has rated the stock with a sell rating, ten have
issued a hold rating and fifteen have given a buy rating to the company’s
stock. The company currently has an average rating of Buy and a consensus price
target of $112.70. Read more …
Intel (NASDAQ:INTC) was downgraded by equities researchers
at UBS Group from a “buy” rating to a “hold” rating in a report released on
Thursday, The Fly reports. Several other brokerages also recently weighed in on
INTC. Goldman Sachs Group downgraded shares of Intel from a “neutral” rating to
a “sell” rating and decreased their target price for the company from $49.00 to
$44.00 in a research note on Friday, August 10th. Needham & Company LLC
restated a “buy” rating and issued a $60.00 target price on shares of Intel in
a research note on Thursday, August 9th. Sanford C. Bernstein set a $42.00
target price on shares of Intel and gave the company a “sell” rating in a
research note on Thursday, August 9th. Stifel Nicolaus restated a “neutral”
rating and issued a $52.00 target price on shares of Intel in a research note
on Thursday, August 9th. Finally, BNP Paribas set a $54.00 target price on
shares of Intel and gave the company a “neutral” rating in a research note on
Thursday, August 9th. Six investment analysts have rated the stock with a sell
rating, sixteen have issued a hold rating and twenty-one have given a buy
rating to the company. The company presently has an average rating of “Hold”
and a consensus price target of $55.56. Read more …
No comments:
Post a Comment